Our 8th Giving Day was a Resounding success! Thank you to all who made a gift during the day. If you missed your opportunity to give, you can still come together for uc irvine and give by clicking here!

If you missed the opportunity to participate in Giving Day, it’s not too late to support Neurology! You may make a gift anytime using our general online giving form: Donation - Brilliant Future: The Campaign for UCI Secure giving.

As of 2022, there were more than seven million people affected by neurodegenerative disease in the United States. As our population ages, current estimates predict that more than 20 million Americans will suffer from a neurodegenerative disease by 2050, with Alzheimer's disease, Parkinson’s disease, multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) comprising the vast majority of new cases.  

Nearly every resident of Orange County will be personally impacted by neurodegenerative disease – either diagnosed with a neurodegenerative disease, caring for an affected family member, or knowing the plight of an extended family member or close friend suffering from a neurodegenerative disease. Despite the immense scope of this problem, we still have little to offer in the way of treatments that change the course of disease highlighting the dire need for more research in this field. Of all the organ systems of the human body, the central nervous system is by far the most complex and most difficult to research and understand.

At UC Irvine, we are conducting leading-edge basic research that aims to delineate mechanisms of neurodegenerative diseases and identify robust and reliable biomarkers that are easy to obtain, are specific to individual diseases, and will permit us to accurately assess responses to putative treatments. Our research teams hope to identify new targets for disease prevention and for the creation of disease-modifying treatments as well as approaches to improve the delivery of novel therapeutics to the brain and spinal cord. The ultimate goal of our research is to develop new therapies for neurodegenerative diseases and advance these therapies to first in-human clinical trials, bringing powerful new therapies to patients who need them most.

Together with your support, we aim to identify novel targets and pathways that will form the basis for the development of powerful therapies to treat some of the most devastating neurodegenerative diseases such as Parkinson’s, Alzheimer’s, MS, ALS and others. The generosity of forward-thinking philanthropists who share our commitment to the mission remains one of the most powerful ways to propel and advance our research in service of humanity and the common good. Your support is critical. We can’t do this work without you. Join us today.

Neurology Donor Map
Rank State Gifts
1 CA 4
2 AA 0
2 AE 0
Last But Not Least!
Congratulations to Tse-Wen Chen, a current student, whose gift to Solar Car Engineering Student Group won the Last But Not Least Challenge! With your gift Tse-Wen, $1000 in bonus funds will be awarded to Solar Car Engineering, thanks to the generous support of UCI Foundation trustees Gary and Melanie Singer!
Parent Power Hour 25 gift Challenge
Power Hour? How about a power 15-minutes?! Congratulations to our UCI Parent and Family community for coming together in record time to unlock $10,000 in support for Campus Organizations and Volunteer Programs! Keep the momentum going and support some of our outstanding matches and challenges below!
25 / 25 Gifts
1965 Challenge
Congratulations to Hilary Lapks! Your gift to Men's Volleyball just unlocked $1,965 in bonus funds for the program!
1,965 / 1,965 Gifts
Early Bird Challenge
Congratulations to Darcy Wilson-Jones (LGBT Resource Center), Katy Young (School of the Arts/Dance), Charlton Lee (Social Sciences Student Awards) and Rick Emerling (UCI Retirees Association Scholarships), for winning our Early Bird Challenge! $500 in bonus funds will be added to each of these funds in your honor!
Don't forget to share!

Questions? See our FAQ.

Or you can contact us at james.yokelle@uci.edu.